Methods for the analysis of nonbenzodiazepine hypnotic drugs in biological matrices

Bioanalysis

Volumn 4, Issue 3, 2012, Pages 291-304

  Tonon, Milena Araújo ^a   Bonato, Pierina Sueli ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ANALYTIC METHOD; CAPILLARY ELECTROPHORESIS; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG ISOLATION; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INSOMNIA; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; RECOMMENDED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION;

ACETAMIDES; AZABICYCLO COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CAPILLARY; HUMANS; HYPNOTICS AND SEDATIVES; MASS SPECTROMETRY; PIPERAZINES; PYRIDINES; PYRIMIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84856919378     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.313     Document Type: Review

References (79)

1. National Institutes of Health State of the Science Conference Statement. Manifestations and management of chronic insomnia in adults 13-15 June 2005. Sleep 28(9), 1049-1057 (2005).
2. Curry DT, Eisenstein RD, Walsh JK. Pharmacologic management of insomnia: past, present and future. Psychiatr. Clin. N. Am. 29, 871-893 (2006). (Pubitemid 44751930)
3. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J. Clin. Sleep Med. 4(5), 487-504(2008).
4. Nutt DJ, Stahl SM. Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J. Psychopharmacol. 24(11), 1601-1612 (2011).
5. Kintz P. Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes. Anal. Bioanal. Chem. 388, 1467-1474 (2007). (Pubitemid 47150873)
6. Cluydts R. A breakthrough in pharmacologic management of insomnia: overview of the clinical profile of zaleplon. J. Clin. Pychiatry 4(1), 45-48 (2002).
7. Rosen AS, Fournie P, Darwisha M, Danjoub P, Troya SM. Zaleplon pharmacokinetics and absolute bioavailability. Biopharm. Drug Dispos. 20, 171-175 (1999). (Pubitemid 29137676)
8. Drover D, Lemmens H, Naidu S, Cevallos W, Darwish M, Stanski D. Pharmacokinetics, pharmacodynamics and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. Clin. Ther. 22(12), 1443-1461 (2000). (Pubitemid 32056083)
9. Feng F, Jiang J, Dai H, Wu J. Development and validation of a high-performance liquid chromatography electrospray ionization mass spectrometry assay for the determination of zaleplon in human plasma. J. Chromatogr. Sci. 41, 1-5 (2003).
10. Giroud C, Augsburger M, Menetrey A, Mangin P. Determination of zaleplon and zolpidem by liquid chromatography-turbo-ionspray mass spectrometry: application to forensic cases. J. Chromatogr. B 789, 131-138 (2003). (Pubitemid 36513794)
11. Horstkötter C, Schepmann D, Blaschke G. Separation and identification of zaleplon metabolites in human urine using capillary electrophoresis with laser induced fluorescence detection and liquid chromatography-mass spectrometry. J. Chromatogr. A 1014, 71-81 (2003). (Pubitemid 37311159)
12. Moore KA, Zemrus TL, Ramcharitar V, Levine B, Fowler DR. Mixed drug intoxication involving zaleplon ('Sonata1'). Forensic Sci. Int. 134, 120-122 (2003).
13. Anderson DT, Budd RD. Zaleplon (Sonata®) analysis in postmortem specimens by gas chromatography-electron capture detection. J. Anal. Toxicol. 33, 481-485 (2009).
14. Foda NH, Elbary AA, El-Gazayerly O. Reversed-phase liquid chromatographic determination of zaleplon in human plasma and its pharmacokinetic application. Anal. Lett. 39, 1891-1905 (2006). (Pubitemid 43982309)
15. Zhang B, Zhang Z, Tian Y, Xu F, Chen Y. High-performance liquid chromatography- atmospheric pressure chemical ionisation-mass spectrometry determination of zaleplon in human plasma. J. Pharmaceut. Biomed. 40, 707-714 (2006). (Pubitemid 43227394)
16. Hempel G, Blaschke G. Direct determination of zolpidem and its main metabolites in urine using capillary electrophoresis with laser-induced fluorescence detection. J. Chromatogr. B 675, 131-137 (1996). (Pubitemid 26038759)
17. Nirogi RVS, Kandikere VN, Shrivasthava W, Mudigonda K. Quantification of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection. Biomed. Chromatogr. 20, 1103-1108 (2006). (Pubitemid 44697051)
18. Ptácek P, Macek J, Klíma J. Rapid and simple method for the determination of zolpidem in human plasma by high performance liquid chromatography. J. Chromatogr. B 694, 409-413 (1997). (Pubitemid 27289515)
19. Ring PR, Bostick JM. Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection. J. Pharmaceut. Biomed. 22, 495-504 (2000). (Pubitemid 30151239)
20. Bhatt J, Jangid A, Shetty R et al. Quantification of zolpidem in human plasma by liquid chromatography electrospray ionization tandem mass spectrometry. Biomed. Chromatogr. 20, 736-742 (2006). (Pubitemid 44203167)
21. Gaillard Y, Pépin G. Screening and identification of drugs in human hair by high performance liquid chromatography- photodiode-array UV detection and gas chromatography-mass spectrometry after solid-phase extraction. A powerful tool in forensic medicine. J. Chromatogr. A 762, 251-267 (1997). (Pubitemid 27122836)
22. Villain M, Chèzeb M, Tracqui A, Ludes B, Kintz P. Windows of detection of zolpidem in urine and hair: application to two drug facilitated sexual assaults. Forensic Sci. Int. 143, 157-161 (2004). (Pubitemid 38881443)
23. Chèze M, Duffort G, Deveaux M, Pépin G. Hair analysis by liquid chromatography- tandem mass spectrometry in toxicological investigation of drug-facilitated crimes: report of 128 cases over the period June 2003-May 2004 in metropolitan Paris. Forensic Sci. Int. 153, 3-10 (2005). (Pubitemid 41008645)
24. Pelander A, Ristimaa J, Rasanen I, Vuori E, Ojanper' I. Screening for basic drugs in hair of drug addicts by liquid chromatography-time-of-flight mass spectrometry. Drug Monit. 30 (6), 717-726 (2008).
25. Kim J, Lee S, In S, Choi H, Chung H. Validation of a simultaneous analytical method for the detection of 27 benzodiazepines and metabolites and zolpidem in hair using LC-MS/MS and its application to human and rat hair. J. Chromatogr. B 879, 878-886 (2011).
26. Gaillard Y, Pepin G. Use of high-performance liquid chromatography with photodiodearray UV detection for the creation of a 600-compound library. Application to forensic toxicology. J. Chromatogr. A 763, 149-163 (1997). (Pubitemid 27149982)
27. Keller T, Schneider A, Tutsch-Bauer E. GC-MS determination of zolpidem in postmortem specimens in a voluntary intoxication. Forensic Sci. Int. 106, 103-108 (1999).
28. Reidy L, Gennaro W, Steele BW, Walls HC. The incidence of zolpidem use in suspected DUI drivers in Miami-Dade Florida: a comparative study using immunalysis Zolpidem ELISA KIT and gas chromatography-mass spectrometry screening. J. Anal. Toxicol. 32, 688-694 (2008).
29. Lee HK, Ho CS, Iu YPH, Lai PSJ, Shek CC, Lo YC. Development of a broad toxicological screening technique for urine using ultra-performance liquid chromatography and time-of-flight mass spectrometry. Anal. Chim. Acta 649, 80-90 (2009).
30. Wang Q, Sun L, Lau CE. Determination of zolpidem in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J. Chromatogr. B 734, 299-305 (1999).
31. Takayasu T, Ishida Y, Kimura A, Kawaguchi M, Kondo T. Distribution of zolpidem in body fluids and organ tissues in five autopsy cases. Forensic Toxicol. 26, 80-84 (2008).
32. Gunnar T, Ariniemi K, Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography- electron impact mass spectrometry. J. Mass Spectrom. 40, 739-753 (2005). (Pubitemid 40905239)
33. Badawi N, Simonsen KW, Steentoft A, Bernhoft IM, Linnet K. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. Clin. Chem. 55(11), 2004-2018 (2009).
34. Bassan DM, Erdmann F, Krüll R. Quantitative determination of 43 common drugs and drugs of abuse in human serum by HPLC-MS/MS. Anal. Bioanal. Chem. 400, 43-50 (2011).
35. Clerck I, Daenens P. Development of a radioimmunoassay for the determination of zolpidem in biological samples. Analyst 122, 1119-1124 (1997). (Pubitemid 27474856)
36. Fernandez C, Gimenez F, Mayrargue J, Thuillier A, Farinotti R. Degradation and racemization of zopiclone enantiomers in plasma and partially aqueous solutions. Chirality 7, 267-271 (1995).
37. Piperaki S, Parisi-Poulo M. Enantiomeric separation of zopiclone, its metabolites and products of degradation on a b-ciclodextrin bonded phase. J. Chromatogr. A 729, 19-28 (1996). (Pubitemid 26135355)
38. Wessell AM, Weart CW. Eszopiclone (Lunesta®) for treatment of transient and chronic insomnia. Am. Fam. Physician 71, 2359-2360 (2005). (Pubitemid 40874924)
39. Mistri HN, Jangid AG, Pudage A, Shrivastav P. HPLC-ESI-MS/MS validated method for simultaneous quantification of zopiclone and its metabolites, N-desmethyl zopiclone and zopiclone-N-oxide in human plasma. J. Chromatogr. B 864, 137-148 (2008).
40. Fernandez C, Baune B, Gimenez F, Thuillier A, Farinotti R. Determination of zopiclone enantiomers in plasma by liquid chromatography using a chiral cellulose carbamate column. J. Chromatogr. Biomed. 572, 195-202 (1991).
41. Foster RT, Caille G, Ngo A, Lemko CH, Kherani R, Pasutto FM. Stereospecif high-performance liquid chromatographic assay of zopiclone in human plasma. J. Chromatogr. B 658, 161-166 (1994). (Pubitemid 24261974)
42. Fernandez C, Gimenez F, Baune B, Maradeix V, Thuillier A, Farinotti R. Determination of the enantiomers of zopiclone and two chiral metabolites in urine using an automated coupled achiral-chiral chromatographic system. J. Chromatogr. Biomed. 617, 271-278 (1993). (Pubitemid 23248374)
43. Fernandez C, Alet P, Davrinche C et al. Stereoselective distribution and stereoconversion of zopiclone enantiomers in plasma and brain tissues in rats. J. Pharm. Pharmac. 54, 335-340 (2002). (Pubitemid 34232334)
44. Tonon MA, Jabor VAP, Bonato PS. Enantioselective analysis of zopiclone and its metabolites in plasma by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 400, 3517-3525 (2011).
45. Stanley C, Mitchell P, Kaye CM. Simple and sensitive method for monitoring zopiclone in plasma by high-performance liquid chromatography with fluorescence detection. Analyst 110, 83-84 (1985). (Pubitemid 15195993)
46. Gebauer MG, Alderman CP. Validation of a high performance liquid chromatographic method for the enantioespecific quantitation of zopiclone in plasma. Biomed. Chromatogr. 16, 241-246 (2002). (Pubitemid 34537467)
47. Nirogi RVS, Kandikere VN, Mudigonda K. Quantitation of zopiclone and desmethylzopiclone in human plasma by high-performance liquid chromatography using fluorescence detection. Biomed. Chromatogr. 20, 794-799 (2006). (Pubitemid 44203176)
48. Royer-Morrot MJ, Rambourg M, Jacob I, Bauer P, Royer RJ. Determination of zopiclone in plasma using column liquid chromatography with ultraviolet detection. J. Chromatogr. Biomed. 581, 291-299 (1992).
49. Paw B, Miszta G. Rapid and simple method for the determination of zopiclone in plasma by HPLC. J. Liq. Chrom. Rel. Technol. 23(18), 2873-2882 (2000).
50. Gjerde H, øiestad EL, øiestad AML et al. Comparison of zopiclone concentrations in oral fluid sampled with Intercept® oral specimen collection device and Statsure Saliva Sampler' and concentrations in blood. J. Anal. Toxicol. 34, 590-593 (2010).
51. Villain M, Chèzeb M, Tracquia A, Ludes B, Kintz P. Testing for zopiclone in hair application to drug-facilitated crimes. Forensic Sci. Int. 145, 117-121 (2004). (Pubitemid 39296628)
52. Irving RC, Dickson SJ. The detection of sedatives in hair and nail samples using tandem LC-MS/MS. Forensic Sci. Int. 166, 58-67 (2007). (Pubitemid 46162012)
53. Lips AGAM, Lameijer W, Fokkens RH, Nibbering NMM. Methodology for the development of a drug library based upon collision-induced fragmentation for the identification of toxicologically relevant drugs in plasma samples. J. Chromatogr. B 759, 191-207 (2001). (Pubitemid 32575280)
54. Gergov M, Boucher B, Ojanpera I, Vuori E. Toxicological screening of urine for drugs by liquid chromatography-time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Commun. Mass Spectrom. 15, 521-526 (2001). (Pubitemid 32391085)
55. Nordgren HK, Bodin K, Beck O. Chromatographic screening for zopiclone and metabolites in urine using liquid chromatography and liquid chromatography- mass spectrometry techniques. Ther. Drug Monit. 24, 410-416 (2002). (Pubitemid 34553208)
56. Kataev SS, Zelenina NB, Khomov YA, Koksharova NV, Daiekh M. Determination of zopiclone in urine by gas chromatography- mass spectrometry. J. Anal. Chem. 62 (5), 458-462 (2007). (Pubitemid 46719005)
57. Yilmaz S. Adsorptive stripping voltammetric determination of zopiclone in tablet dosage forms and human urine. Colloid Surface B71, 79-83 (2009).
58. Hempel G, Blaschke G. Enantioselective determination of zopiclone and its metabolites in urine by capillary electrophoresis. J. Chromatogr. B 675, 139-146 (1996). (Pubitemid 26036977)
59. Stanke F, Jourdil N, Bessard J, Bessard G. Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection. J. Chromatogr. B Biomed. Appl. 675, 43-51 (1996). (Pubitemid 26036969)
60. Gunnar T, Mykk'nen S, Ariniemi K, Lillsunde P. Validated semiquantitative/ quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J. Chromatogr. B 806, 205-219 (2004). (Pubitemid 38686509)
61. Gunnar T, Ariniemi K, Lillsunde P. Determination of 14 benzodiazepines and hydroxy metabolites, zaleplon and zolpidem as tert-butyldimethylsilyl derivatives compared with other common silylating reagents in whole blood by gas chromatography-mass spectrometry. J. Chromatogr. B 818, 175-189 (2005). (Pubitemid 40331822)
62. Langel K, Gunnar T, Ariniemi K, Rajam'ki O, Lillsunde P. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry. J. Chromatogr. B 879, 859-870 (2011).
63. Gunnar T, Ariniemi K, Lillsunde P. Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and a hydroxy metabolites, zaleplon and zopiclone in whole blood. J. Mass Spectrom. 41, 741-754 (2006). (Pubitemid 44023102)
64. Kintz P, Villain M, Ludes B. Testing for the undetectable in drug-facilitated sexual assault using hair analyzed by tandem mass spectrometry as evidence. Ther. Drug Monit. 26(2), 211-214 (2004).
65. Smink BE, Brandsma JE, Dijkhuizen A et al. Quantitative analysis of 33 benzodiazepines, metabolites and benzodiazepine-like substances in whole blood by liquid chromatography-(tandem) mass spectrometry. J. Chromatogr. B 811, 13-20 (2004). (Pubitemid 39348843)
66. Nordgren HK, Beck O. Multicomponent screening for drugs of abuse direct analysis of urine by LC-MS/MS. Ther. Drug Monit. 26 (1), 90-97 (2004). (Pubitemid 38140917)
67. Smyth WF, Joyce C, Ramachandran VN, O'Kane E, Coulter D. Characterisation of selected hypnotic drugs and their metabolites using electrospray ionisation with ion trap mass spectrometry and with quadrupole time-of flight mass spectrometry and their determination by liquid chromatography- electrospray ionisation ion trap mass spectrometry. Anal. Chim. Acta 506, 203-214 (2004). (Pubitemid 38201369)
68. Kratzsch C, Tenberken O, Peters FT, Weber AA, Kraemer T, Maurer HH. Screening, library-assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography-mass spectrometry with atmospheric pressure chemical ionization. J. Mass Spectrom. 39, 856-872 (2004). (Pubitemid 39173092)
69. Laloup M, Fernandez MMR, Boeck G, Wood M, Maes V, Samyn N. Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of 26 benzodiazepines and metabolites, zolpidem and zopiclone, in blood, urine and hair. J. Anal. Toxicol. 29, 616-626 (2005). (Pubitemid 41803347)
70. Villain M, Concheiro M, Cirimele V, Kintz P. Screening method for benzodiazepines and hypnotics in hair at pg/mg level by liquid chromatography-mass spectrometry/mass spectrometry. J. Chromatogr. B 825, 72-78 (2005). (Pubitemid 41262480)
71. Kintz P, Villain M, Concheiro M, Cirimele V. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS. Forensic Sci. Int. 150, 213-220 (2005). (Pubitemid 41583225)
72. Quintela O, Sauvage F, Charvier F, Gaulier J, Lachatre G, Marquet P. Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites and analogs in urine: method with forensic applications. Clin. Chem. 52(7), 1346-1355 (2006). (Pubitemid 43956027)
73. Miyaguchi H, Kuwayama K, Tsujikawa K et al. A method for screening for various sedative-hypnotics in serum by liquid chromatography/single quadrupole mass spectrometry. Forensic Sci. Int. 157, 57-70 (2006). (Pubitemid 43117201)
74. Øiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 53(2), 300-309 (2007). (Pubitemid 46338275)
75. Concheiro M, Castro A, Quintela O, Cruz A, Lópes-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 39, 2329-2338 (2008).
76. Ishida T, Kudo K, Hayashida M, Ikeda N. Rapid and quantitative screening method for 43 benzodiazepines and their metabolites, zolpidem and zopiclone in human plasma by liquid chromatography/mass spectrometry with a small particle column. J. Chromatogr. B 877, 2652-2657 (2009).
77. Simonsen KW, Hermansson S, Steentoft A, Linnet K. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 34, 332-341 (2010).
78. Bjørk MK, Nielsen MKK, Markussen LØ, Klinke HB, Linnet K. Determination of 19 drugs of abuse and metabolites in whole blood by high performance liquid chromatography- tandem mass spectrometry. Anal. Bioanal. Chem. 396, 2393-2401 (2010).
79. Salomonea A, Geracea E, Brizio P, Gennaroa MC, Vincentia M. A fast liquid chromatography-tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest. J. Pharmaceut. Biomed. 56, 582-591 (2011).